Thank you! Welcome to Cambridge Biocapital.
Oops! Something went wrong while submitting the form. Make sure you submit a valid email.
Let's talk
Cambridge Biocapital is the independent weekly newsletter covering business, funding and science news in one of the largest biotech & VC ecosystems in the world.
Cambridge Biocapital is the weekly newsletter covering the business, funding and science news in one of the largest biotech ecosystems in the world. It is a ad-supported publication, free to read for subscribers and website users.
Cambridge Biocapital is a unique publication in its scope and outreach. It attains most of the major players and stakeholders involved in the biotech scene: startup founders and employees, scientists, research institutions, investment firms, corporates, universities and regulatory agencies.
Display a branded banner and a description of your service. These are displayed at the beginning of the newsletter.
It includes:
• Branded banner 600 x 600 px.
• Up to 150 words service description.
Are you hiring or want to promote an event? You may want to reach out to graduates and professionals reading Cambridge Biocapital each week.
It includes:
• Branded banner 600 x 300 px.
• Up to 100 words describing your post or event.
Each edition features two Beyond Biotech items. Your service or event may fit better with such section if you want to talk up some good news.
It includes:
• Branded banner 600 x 300 px.
• Up to 70 words describing your initiative
Lisa Lampersberg
PhD student, University of Cambridge
John Doe
Company Ltd.
John Doe
Company Ltd.
Biotech / Deep-tech startups
55% work in a biotech/deep-tech startups & CROs.
Big Pharma or Corporate
10% work in big pharma or corporate.
Investment Firms
20% work at investment firms.
Research Institutions or Universities
15% work at research institutions or universities.
UK
80% are from United Kingdom of which 70% are from Cambridge, Oxford and London area.
US
Roughly, 8% of the audience come from different locations within the United States.
Europe
12% are from the rest of Europe of which 60% are from Spain and 15% are from Germany.
Research Institutions & Universities
University of Cambridge, University of Oxford, Cambridge Judge Business School, Laboratory of Molecular Biology (LMB), Instituto de Empresa (IE), etc.
Startups & CROs
Maxion Therapeutics, IONTAS, etc.
Corporates
AstraZeneca, Glaxo Smith-Klein, Heidrick & Struggles, etc.
Investment firms
Cambridge Innovation Capital, etc.
Let's talk